Cathy A. Maccormac

Array ( [id] => 7335020 [patent_doc_number] => 20040132151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Novel adenosine deaminase homolog' [patent_app_type] => new [patent_app_number] => 10/738201 [patent_app_country] => US [patent_app_date] => 2003-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13129 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132151.pdf [firstpage_image] =>[orig_patent_app_number] => 10738201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252368 [patent_doc_number] => 20040259197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Recombinant bovine pancreatic desoxyribonuclease I with high specific activity' [patent_app_type] => new [patent_app_number] => 10/737601 [patent_app_country] => US [patent_app_date] => 2003-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15190 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259197.pdf [firstpage_image] =>[orig_patent_app_number] => 10737601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6996266 [patent_doc_number] => 20050136044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents' [patent_app_type] => utility [patent_app_number] => 10/728723 [patent_app_country] => US [patent_app_date] => 2003-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 25300 [patent_no_of_claims] => 104 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136044.pdf [firstpage_image] =>[orig_patent_app_number] => 10728723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7270367 [patent_doc_number] => 20040058885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Nucleoside diphosphate hydrolase' [patent_app_type] => new [patent_app_number] => 10/451374 [patent_app_country] => US [patent_app_date] => 2003-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23201 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058885.pdf [firstpage_image] =>[orig_patent_app_number] => 10451374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7464607 [patent_doc_number] => 20040166510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Isolated CEL II endonuclease' [patent_app_type] => new [patent_app_number] => 10/688665 [patent_app_country] => US [patent_app_date] => 2003-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10713 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20040166510.pdf [firstpage_image] =>[orig_patent_app_number] => 10688665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7342136 [patent_doc_number] => 20040133936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Enzyme' [patent_app_type] => new [patent_app_number] => 10/362024 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20178 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20040133936.pdf [firstpage_image] =>[orig_patent_app_number] => 10362024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 719627 [patent_doc_number] => 07049123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Deoxyribonuclease, gene encoding same and use thereof' [patent_app_type] => utility [patent_app_number] => 10/670863 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12162 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049123.pdf [firstpage_image] =>[orig_patent_app_number] => 10670863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675276 [patent_doc_number] => 20040126842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Mutant E. coli strains, and their use for producing recombinant polypeptides' [patent_app_type] => new [patent_app_number] => 10/655042 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13726 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126842.pdf [firstpage_image] =>[orig_patent_app_number] => 10655042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 626941 [patent_doc_number] => 07135324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-14 [patent_title] => 'Viral recombinases, related articles, and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/656868 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 16756 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/135/07135324.pdf [firstpage_image] =>[orig_patent_app_number] => 10656868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 679422 [patent_doc_number] => 07083930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Human choline acetyltransferase' [patent_app_type] => utility [patent_app_number] => 10/650721 [patent_app_country] => US [patent_app_date] => 2003-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11130 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/083/07083930.pdf [firstpage_image] =>[orig_patent_app_number] => 10650721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033614 [patent_doc_number] => 20050032123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Oncoprotein protein kinase' [patent_app_type] => utility [patent_app_number] => 10/648823 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18226 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032123.pdf [firstpage_image] =>[orig_patent_app_number] => 10648823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256326 [patent_doc_number] => 20050075489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'DSP-5 dual-specificity phosphatase' [patent_app_type] => utility [patent_app_number] => 10/644554 [patent_app_country] => US [patent_app_date] => 2003-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19713 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075489.pdf [firstpage_image] =>[orig_patent_app_number] => 10644554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7326835 [patent_doc_number] => 20040253221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Novel pla1' [patent_app_type] => new [patent_app_number] => 10/398869 [patent_app_country] => US [patent_app_date] => 2003-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8664 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253221.pdf [firstpage_image] =>[orig_patent_app_number] => 10398869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7382806 [patent_doc_number] => 20040029231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Mutant E.coli strains, and their use for producing recombinant polypeptides' [patent_app_type] => new [patent_app_number] => 10/633577 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6852 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029231.pdf [firstpage_image] =>[orig_patent_app_number] => 10633577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905145 [patent_doc_number] => 20050100540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Platelet-activating factor acetylhydrolase' [patent_app_type] => utility [patent_app_number] => 10/633735 [patent_app_country] => US [patent_app_date] => 2003-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23804 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100540.pdf [firstpage_image] =>[orig_patent_app_number] => 10633735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7466385 [patent_doc_number] => 20040101942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Sulfohydrolases, corresponding amino acid and nucleotide sequences, sulfohydrolase preparations, processes, and products thereof' [patent_app_type] => new [patent_app_number] => 10/626671 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23428 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101942.pdf [firstpage_image] =>[orig_patent_app_number] => 10626671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 740752 [patent_doc_number] => 07029900 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-18 [patent_title] => 'Type II restriction endonuclease BtgZI, obtainable from Bacillus thermoglucosidasius 36A and a process for producing the same' [patent_app_type] => utility [patent_app_number] => 10/617361 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 3908 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/029/07029900.pdf [firstpage_image] =>[orig_patent_app_number] => 10617361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7088921 [patent_doc_number] => 20050009034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Novel type II restriction endonuclease, CstMI, obtainable from corynebacterium striatum M82B and a process for producing the same' [patent_app_type] => utility [patent_app_number] => 10/616689 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4996 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009034.pdf [firstpage_image] =>[orig_patent_app_number] => 10616689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 648975 [patent_doc_number] => 07115407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-03 [patent_title] => 'Recombinant type II restriction endonucleases, MmeI and related endonucleases and methods for producing the same' [patent_app_type] => utility [patent_app_number] => 10/616624 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 10590 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115407.pdf [firstpage_image] =>[orig_patent_app_number] => 10616624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 634032 [patent_doc_number] => 07129088 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-31 [patent_title] => 'Plant caffeic acid 3-O-methyltransferase homologs' [patent_app_type] => utility [patent_app_number] => 10/464610 [patent_app_country] => US [patent_app_date] => 2003-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12293 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/129/07129088.pdf [firstpage_image] =>[orig_patent_app_number] => 10464610 [rel_patent_id] =>[rel_patent_doc_number] =>)